ReviewJournal of hematology & oncology2024

Novel clinical risk stratification and treatment strategies in relapsed/refractory peripheral T-cell lymphoma.

Esther Wei Yin Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.